Clinical trial
Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients
Recruiting now · Not applicable · 1 countries · Registry ID NCT06780813
What this study is about
The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care. Appropriate wound care and tissue oxygenation are of special importance for wound healing. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications as to date, there is absence of relevant data.
Basic eligibility
Full registry criteria
Treatments and study arms
Supplemental oxygen therapy
In this grou participants will receive supplemental oxygen in the form of a Venturi mask upon low oxygen saturation in oximetry (SaO2\<95%) and a nasal oxygen mask in all other cases during the first 2 postoperative days
Primary outcomes
Surgical site infections will be evaluated using the Southampton wound scoring system
The proportion of patients developing SSI-related systemic inflammatory response will be documented
Study locations
1 locations were listed when this page was built. The first 40 are shown.